Test blood and antibody markers for suspected acute stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study looks at blood tests to find signs of immune activity after a suspected stroke. It may help doctors diagnose stroke faster and better understand what is happening in the body soon after symptoms start.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You have suspected acute stroke based on a screening check (FAST, LAPSS, or ROSIER score)
- Your stroke symptoms started within the last 24 hours
- You can give informed consent (or a study-approved way of getting consent)
- Recent medical history should not include certain brain-related problems in the last 30 days
- Symptoms should not clearly be more than 24 hours old
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether certain blood tests taken after a mechanical thrombectomy (a procedure to remove a blood clot from the brain) can help predict how well a patient will recover from a stroke. The goal is to find early signs that might guide future treatment and improve outcomes.
This hospital study looks at blood and clotting (coagulation) measurements in people who arrive with specific types of stroke or brain bleeding not caused by injury. It may help doctors better understand clotting changes after these events and improve care decisions.
This study looks at how the nervous system's automatic functions (like heart rate and blood pressure) change after a stroke. It uses MRI scans and blood tests to find patterns that might help doctors better understand and treat these changes.
This trial looks at certain molecules in the blood (called circRNA) in people who have a new ischemic stroke (a blockage in a blood vessel). It may help researchers understand what these blood signals mean soon after stroke, which could guide future treatments or monitoring.
This study uses blood tests to quickly identify the type of stroke in patients arriving at the emergency room. It aims to help doctors choose the best treatment early on.
This trial looks at blood “inflammation-related” biomarkers to understand what happens early after certain sudden brain events. It may help doctors predict outcomes and tailor treatment for people like those with stroke types that sometimes need a clot-removal procedure.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.